Position in AZN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$135,578
-$5,434 QoQ
Shares Held
715
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#450
of 567 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARMSTRONG ADVISORY GROUP, INC holds $13,083,941 across 15 Drug Manufacturers - General names. AZN ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,723 | $8,063,768 | |
| 2 | ABBV |
AbbVie Inc.
|
9,193 | $2,313,326 | |
| 3 | JNJ |
Johnson & Johnson
|
5,400 | $1,371,438 | |
| 4 | PFE |
Pfizer Inc
|
10,400 | $250,432 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,833 | $235,540 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,009 | $230,998 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,606 | $202,902 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
715 | $135,578 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,578 | 715 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $141,012 | 715 | Shares | Sole | 2026-04-10 | |
| No filing history on record for this holder in this stock. | ||||||